Primecuts – This Week In The Journals

May 27, 2014
Primecuts – This Week In The Journals

By Matthew Vorsanger, MD

Peer Reviewed

As we spend time with family and friends on this beautiful Memorial Day weekend, we also ponder the senseless and tragic killings recently committed in Isla Vista, California. Between the interviews of experts, eyewitnesses, and acquaintances of the killer and the victims, we are left to wonder how these tragedies can be prevented in the future . With the health of our nation in mind, we also turn to recently published advancements in medical literature in this week’s PrimeCuts.…

Read more »

Gay Men, Barebacking and the New Little Blue Pill: The awkward interface of medicine and gay sex.

May 23, 2014
Gay Men, Barebacking and the New Little Blue Pill: The awkward interface of medicine and gay sex.

By Richard E. Greene, MD

Peer Reviewed

In July of 2012, the FDA approved the use of Tenofovir-Emtricitabine (Truvada, a single blue pill) daily as Pre-Exposure Prophylaxis (PrEP) in men with persistent risk for contracting HIV infection. The idea of PrEP has ignited a firestorm of concern among healthcare providers about how, when and in whom to use PrEP, if at all. Indeed, some believe that PrEP will usher in a new era of drug resistant new infections with HIV, or encourage men on…

Read more »

From The Archives: Metabolic Syndrome: Fact or Myth?

May 22, 2014
From The Archives: Metabolic Syndrome: Fact or Myth?

Please enjoy this post from the archives dated September 30, 2011

By Vicky Jones, MD

A 40-year-old female presented to her primary care provider with a chief complaint of weight gain over the past year.  She wants to be fully evaluated for any kind of medical disorder that could have caused it.  She has been seen by multiple specialists but no one can give her a “straight diagnosis”.  Their advice is for her to lose weight.  She insists she never had problems with her weight…

Read more »

Help Versus Hope: Acetylcholinesterase Inhibitors in Alzheimer’s Disease

May 21, 2014
Help Versus Hope: Acetylcholinesterase Inhibitors in Alzheimer’s Disease

By Jonathan Gursky

Peer Reviewed

Approximately 5.2 million Americans are currently living with Alzheimer’s disease (AD) , with this number expected to triple by the year 2050 . Alzheimer’s disease is now the sixth leading cause of death in the United States and accounts for $100 billion in healthcare expenditures each year . Nevertheless, the most devastating and far-reaching effects of Alzheimer’s disease hit close to home. While those with the disease progressively lose their memory, speech, and independence, it is the caretaker…

Read more »

Primecuts – This Week In The Journals

May 20, 2014
Primecuts – This Week In The Journals

By Mark Adelman, MD

Peer Reviewed

The Centers for Disease Control and Prevention CDC confirmed on May 12 that a second case of Middle East Respiratory Syndrome (MERS) was present in the U.S. This patient in Florida is a resident of Saudi Arabia, much like the first U.S. case of MERS, which occurred in a traveler from Saudi Arabia to Indiana that the CDC announced 10 days earlier. While the CDC cautions that vigilance is needed to recognize and respond to this emerging infectious disease,…

Read more »

Timekeeping

May 16, 2014
Timekeeping

By Nancy Hernandez

 

I did not know you until that time,

We scurried into your room

And found you pulseless, breathless, lifeless.

I was asked to keep

Time.

 

Fumbling for paper, I resorted to skin,

Marking the time we started to

Restore your blood flow.

Pumping in air,

Compressing your chest,

As you were infused with epinephrine,

I kept time.

 

Your story started pouring in,

You were post-op for an

Incision and drainage

Of your limb amputation site -

A diabetic’s fight.…

Read more »

HotSpots: The Evolution of Medicine

May 15, 2014
HotSpots: The Evolution of Medicine

Welcome to HotSpots. In this series, we highlight unique websites of interest to the medical profession. Feel free to make suggestions for sites that should be featured in this series by clicking the comment field or sending us an email.

Matthew Vorsanger, MD

When we consider the accomplishments that have been made in the history of the field of medicine, taking a step back can reveal an astounding landscape. Please see below for a remarkable infographic produced by Aria Cahill on the Evolution of Medicine.


Read more »

New Cholesterol Guidelines: How Safe Are High-Potency Statins?

May 14, 2014
New Cholesterol Guidelines: How Safe Are High-Potency Statins?

By Molly Anderson

Peer Reviewed

Managing hyperlipidemia is a mainstay of cardiovascular risk reduction. The 2013 ACC/AHA guidelines no longer target specific low-density lipoprotein (LDL)-cholesterol levels, but recommend lipid-lowering therapies of varying intensity based on the predicted risk of cardiovascular events . Adoption of the new guidelines would result in millions more Americans receiving high-potency statins; it is therefore important to investigate potential dangers associated with aggressive therapy and the long-term implications for patients.

Many studies have shown that strict adherence to lipid-lowering medications improves…

Read more »